1. Mangiferin Improves Hepatic Lipid Metabolism Mainly Through Its Metabolite-Norathyriol by Modulating SIRT-1/AMPK/SREBP-1c Signaling
   Jian Li et al, 2018, Frontiers in Pharmacology CrossRef
2. Selenium-Enriched Probiotic Alleviates Western Diet-Induced Non-alcoholic Fatty Liver Disease in Rats via Modulation of Autophagy Through AMPK/SIRT-1 Pathway
   Rajat Pant et al, 2023, Biological Trace Element Research CrossRef
3. Integrative evidence construction for resveratrol treatment of nonalcoholic fatty liver disease: preclinical and clinical meta-analyses
   Xuan He et al, 2023, Frontiers in Pharmacology CrossRef
4. Chrysin Attenuates Fructose-Induced Nonalcoholic Fatty Liver in Rats via Antioxidant and Anti-Inflammatory Effects: The Role of Angiotensin-Converting Enzyme 2/Angiotensin (1-7)/Mas Receptor Axis
   Hala Attia et al, 2022, Oxidative Medicine and Cellular Longevity CrossRef
5. Mechanism and Basis of Traditional Chinese Medicine Against Obesity: Prevention and Treatment Strategies
   Chang-hua Zhang et al, 2021, Frontiers in Pharmacology CrossRef
6. Constituents, Pharmacokinetics, and Pharmacology of Gegen-Qinlian Decoction
   Jing-Ze Lu et al, 2021, Frontiers in Pharmacology CrossRef
7. Comparison of the Effect of 8- and 12-Week Aerobic Exercise with Calorie Restriction on the Bax and Bcl-2 Expression in Rats with Non-alcoholic Fatty Liver Disease
   Maryam Mirzaei et al, 2023, Annals of Military and Health Sciences Research CrossRef
8. The Impacts of Herbal Medicines and Natural Products on Regulating the Hepatic Lipid Metabolism
   Sha Li et al, 2020, Frontiers in Pharmacology CrossRef
9. Regulatory effect of a Chinese herbal medicine formula on non-alcoholic fatty liver disease
   Jia-Min Yang et al, 2019, World Journal of Gastroenterology CrossRef
10. Hepatoprotective effect of botanical drug formula on high-fat diet-induced non-alcoholic fatty liver disease by inhibiting lipogenesis and promoting anti-oxidation
    De-Shan Ning et al, 2022, Frontiers in Pharmacology CrossRef